ARK Genomic Revolution ETF Rating → Are you prepared for a Chinese 'invasion?' (From Behind the Markets) (Ad) Free ARKG Stock Alerts $24.57 -0.48 (-1.92%) (As of 06/17/2024 ET) Add Compare Share Share RatingsStock AnalysisChartHeadlinesHoldingsOwnershipRatingsStock AnalysisChartHeadlinesHoldingsOwnershipRatings ARK Genomic Revolution ETF Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.ARKG Aggregate RatingModerate Buy2.64Holdings in ARKG have an aggregate rating of Moderate Buy based on 411 analyst ratings issued in the past year covering 38 companies (99.2% of the portfolio).ARKG Aggregate Price Target$45.9887.15% UpsideHigh Prediction$68.96Average Prediction$45.98Low Prediction$27.69Holdings in ARKG have an aggregate price target of $45.98 and a range of $27.69 to $68.96 covering 38 companies (99.2% of the portfolio).ARKG Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy10 Buy rating(s)Moderate Buy20 Moderate Buy rating(s)Hold7 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by ARK Genomic Revolution ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 38 ARKG Holdings Export to ExcelWeightIn ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings8.48%TWSTTwist Bioscience$49.00-1.7%2 of 5 stars3.00$46.63 -4.8%8Gap Down7.37%CRSPCRISPR Therapeutics$61.79-2.8%1 of 5 stars2.35$75.71 22.5%17Analyst Forecast5.69%RXRXRecursion Pharmaceuticals$9.37+1.2%2 of 5 stars2.50$14.33 53.0%4Insider Selling5.54%CDNACareDx$13.54-4.6%3 of 5 stars2.60$16.50 21.9%5Gap Down5.07%ARCTArcturus Therapeutics$28.13-9.3%3 of 5 stars3.00$64.86 130.6%7Gap Down4.21%NTLAIntellia Therapeutics$25.17+0.1%3 of 5 stars2.69$64.75 157.3%13Analyst Revision3.84%SDGRSchrödinger$19.89-3.6%1 of 5 stars2.67$40.89 105.6%9Gap Up3.84%IONSIonis Pharmaceuticals$40.76+0.3%4 of 5 stars2.67$58.43 43.3%15Positive News3.79%MRNAModerna$137.90-1.5%4 of 5 stars2.24$129.02 -6.4%173.71%BEAMBeam Therapeutics$24.03-3.4%1 of 5 stars2.38$40.18 67.2%13Short Interest ↓3.14%TXG10x Genomics$19.98-1.3%5 of 5 stars2.54$46.62 133.3%13Positive News2.97%VCYTVeracyte$21.38+2.0%4 of 5 stars2.60$27.50 28.6%5Positive News2.84%NRIXNurix Therapeutics$15.29+0.7%2 of 5 stars2.90$24.10 57.6%10Analyst ForecastNews CoverageGap UpHigh Trading Volume2.78%ACCDAccolade$6.19+0.2%4 of 5 stars2.75$14.14 128.5%16Short Interest ↑2.65%ADPTAdaptive Biotechnologies$3.14+0.3%4 of 5 stars2.67$6.80 116.6%6Positive News2.58%VRTXVertex Pharmaceuticals$473.69-1.5%4 of 5 stars2.52$443.55 -6.4%25Analyst Forecast2.53%EXASExact Sciences$41.33-1.3%4 of 5 stars2.92$93.07 125.2%132.35%TDOCTeladoc Health$10.10+1.0%3 of 5 stars2.33$18.22 80.4%182.29%LABStandard BioTools$2.11-1.9%3 of 5 stars3.00$3.58 69.8%3Positive News2.12%DNAGinkgo Bioworks$0.43-4.5%2 of 5 stars1.67$1.90 343.0%6Short Interest ↓2.09%VEEVVeeva Systems$179.75-2.7%5 of 5 stars2.60$227.95 26.8%20Positive News1.78%MASS908 Devices$5.69-2.1%3 of 5 stars3.00$14.00 146.0%1Positive News1.71%INCYIncyte$62.69+0.9%5 of 5 stars2.44$73.69 17.5%18Positive News1.67%AMGNAmgen$303.28+1.6%5 of 5 stars2.52$305.85 0.8%21Short Interest ↓1.66%PACBPacific Biosciences of California$1.67-5.1%3 of 5 stars2.53$6.38 281.7%15Positive NewsGap Down1.41%PRMEPrime Medicine$6.35-10.7%3 of 5 stars2.83$15.09 137.7%12Gap Up1.36%QSIQuantum-Si$1.33-2.9%1 of 5 stars2.33$2.67 100.5%3Gap Up1.24%ABSIAbsci$3.41-14.3%2 of 5 stars3.00$9.25 171.3%4Short Interest ↓High Trading Volume1.17%NTRANatera$110.42+0.2%2 of 5 stars3.00$101.19 -8.4%16Positive News1.16%CMPSCOMPASS Pathways$6.80+2.1%1 of 5 stars3.00$47.40 597.1%5Short Interest ↑1.14%REGNRegeneron Pharmaceuticals$1,045.37+0.9%4 of 5 stars2.77$998.09 -4.5%22Analyst ForecastInsider Selling1.05%VERVVerve Therapeutics$5.27-2.8%2 of 5 stars2.75$33.00 526.2%81.03%CERSCerus$1.81+4.0%2 of 5 stars2.67$3.83 111.8%3Short Interest ↑Positive News0.90%GHGuardant Health$30.50+1.0%4 of 5 stars2.86$36.91 21.0%14Positive News0.67%RPTXRepare Therapeutics$3.803 of 5 stars3.00$17.33 356.1%40.67%PSNLPersonalis$1.29-5.9%4 of 5 stars3.00$5.00 289.1%30.65%PATHUiPath$11.42-1.0%3 of 5 stars2.11$18.12 58.6%180.03%SNTISenti Biosciences$0.24-4.0%3 of 5 stars3.00$6.00 2,429.5%1Positive News This page (BATS:ARKG) was last updated on 6/18/2024 by MarketBeat.com Staff From Our PartnersBigger Than NVIDIA?With NVIDIA flying high, everyone is looking for the next breakout stock. But right now... There's only ...Behind the Markets | SponsoredBeta testers blew this thing upThis AI trading tool is probably unlike anything you've ever seen before… It scans the entire market and fi...Prosper Trading Academy | SponsoredRadical change coming — do this NOW to protect yourselfI recently uncovered a way the government could use the next crisis as a pretext to gain more control … and ra...Weiss Ratings | SponsoredInflation Is Robbing You Blind! Here’s How to Fight Back!Quietly, inflation has reduced your purchasing power by 29.4% since 2014. So something that cost $100 in 20...American Alternative | SponsoredUnexpected twist to Trump’s trialUnexpected Twist to Trump's Trial Most folks sense there's more to the Trump trial than meets the eye. B...Stansberry Research | SponsoredMissed NVDA? Buy this AI stock NOWAfter Nvidia's record-breaking earnings surge, Wall Street is now selling the stock at the fastest pace in sev...Chaikin Analytics | SponsoredBiden Nomination CANCELED?And I believe when they do take the oath of office, their fingers will be crossed… and America will descend in...The Freeport Society | SponsoredHe Is Giving Away BitcoinAnd my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a v...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ARK Genomic Revolution ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share ARK Genomic Revolution ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
